
South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market
No. of Pages: 114 | Report Code: BMIRE00027546 | Category: Life Sciences
No. of Pages: 114 | Report Code: BMIRE00027546 | Category: Life Sciences
Introduction of Artificial Intelligence to Provide Opportunities to South & Central America Helicobacter
Pylori (H. pylori) Non-invasive Testing Market Players
The advancement in the field of computer technologies has led to the introduction of artificial intelligence technologies, which have been utilized to enhance the diagnosis and predict disease progression and treatment planning. Several studies have shown the capability of artificial intelligence in predicting H. pylori status for diagnosing gastritis. In 2019, Cancer Informatics and Inspirata entered into a technical partnership with DeePathology to grant joint customers the ability to utilize the DeePathology H. pylori decision support system, a screening tool, directly from Dynamyx, a digital pathology solution by Inspirata. The product can enhance reporting accuracy and safely accelerate the H. Pylori diagnostic process. Thus, the emergence of artificial intelligence will offer new opportunities for pharmaceutical companies, which is expected to provide growth opportunities to the helicobacter pylori (H. pylori) non-invasive testing market.
Market Overview
The number of cancer cases in Argentina is increasing at a steady rate. According to WHO, in 2020, ~130,878 new cases of cancer were diagnosed, of which 22,024 were breast cancer, while 15,605 were colorectal cancer and others. Further, ~70,000 deaths are caused by cancer per year, which is the third-highest cancer mortality rate in Latin America. Breast cancer is the most common type, with 73 cases per 100,000 women each year. Moreover, according to OECD, the healthcare expenditure in Argentina has increased. The surge is due to a growing need for health systems, infrastructure, human resources, diagnostics, treatment, and financing owing to the rising number of diseases and infections across the country. These factors are expected to provide significant growth opportunities to the (H. pylori) non-invasive testing market players during the forecast period.
Strategic insights for the South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Strategic Insights
South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Report Scope
Report Attribute
Details
Market size in 2022
US$ 26.14 Million
Market Size by 2028
US$ 34.64 Million
Global CAGR (2022 - 2028)
4.8%
Historical Data
2020-2021
Forecast period
2023-2028
Segments Covered
By Test Type
By Test Method
By End User
Regions and Countries Covered
South and Central America
Market leaders and key company profiles
South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Regional Insights
South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market Segmentation
The South & Central America helicobacter pylori (H. pylori) non-invasive testing market is segmented on test type, test method, end user, and country.
Based on test type, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is segmented into serology, stool antigen, and urea breathe. In 2022, the urea breath segment is expected to hold the largest share of the market. Based on test method, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is bifurcated into laboratory based and point of care. The laboratory based segment is expected to hold a larger share of the market in 2022. Based on end user, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is segmented into hospitals, clinics, and diagnostic laboratories. The diagnostic laboratories segment is expected to hold the largest share of the market in 2022. Based on country, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is segmented into Brazil, Argentina, and the Rest of South & Central America. Further, Brazil is expected to hold the largest share of the market in 2022. Abbott Laboratories; Bio-Rad Laboratories Inc.; CerTest Biotec; Coris BioConcept; DiaSorin S.p.A.; Meridian Bioscience Inc.; QuidelOrtho Corporation; Sekisui Diagnostics; Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd; and Thermo Fisher Scientific Inc. are the leading companies operating in the helicobacter pylori (H. pylori) non-invasive testing market in South & Central America.
The South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market is valued at US$ 26.14 Million in 2022, it is projected to reach US$ 34.64 Million by 2028.
As per our report South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market, the market size is valued at US$ 26.14 Million in 2022, projecting it to reach US$ 34.64 Million by 2028. This translates to a CAGR of approximately 4.8% during the forecast period.
The South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market report:
The South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market value chain can benefit from the information contained in a comprehensive market report.